In a major move against high prescription costs, AstraZeneca has agreed to sell its drugs at a discount through Medicaid, marking a significant win for the Trump administration's healthcare initiative.
AstraZeneca partners with the Trump administration to offer drastically lower drug prices through Medicaid and the upcoming TrumpRx platform, aiming to make medications more accessible to consumers.
Rite Aid has announced the closure of all its locations, following multiple bankruptcies and significant financial struggles. With over 520 stores shut down, customers are left searching for new pharmacies. What does this mean for your medication needs?
President Trump reveals plans for a new website, TrumpRx, aimed at providing discounted prescription medications directly to Americans, particularly benefiting low-income families. This initiative follows Pfizer's agreement to lower drug prices, promising a transformative approach to healthcare access.
President Trump is set to unveil a new strategy to lower drug costs, including the launch of a 'TrumpRx' website for discounted medications and a deal with Pfizer. This move aims to tackle high prescription prices that burden American patients.
A groundbreaking clinical trial reveals that low-dose radiation therapy may provide significant pain relief for individuals suffering from knee osteoarthritis, offering a safer alternative to traditional pain management methods.
President Trump announces a controversial 100% tariff on foreign brand-name drugs, leaving patients and experts questioning the implications for prescription prices and U.S. manufacturing. Will your medications cost more?
A groundbreaking partnership aims to provide low-cost lenacapavir to millions at risk of HIV in low- and middle-income countries, potentially transforming HIV prevention efforts worldwide.
Amidst growing concerns, Tylenol's safety during pregnancy is under scrutiny. Experts and doctors urge pregnant women to consult healthcare providers amidst controversial claims linking the medication to autism.
The Trump administration has sparked debate by proposing restrictions on one medication linked to autism, while advocating for broader access to another under investigation. What does this mean for future healthcare decisions?
